Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.2.SummaryDifference1%
- Check22 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe webpage has undergone significant updates regarding the RGX-121 study for Mucopolysaccharidosis Type II (MPS II), including the removal of detailed descriptions of the therapy and study phases, while adding new terminology related to the study's design and versioning.SummaryDifference32%
- Check66 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 28, 2025.SummaryDifference0.3%
Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.